BST-2006

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBST-2006
Drug Alias Nameautologous PAI-1 inhibited CD34+ stem cell therapy (BetStem therapeutics/University of Florida)BST-2006
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBetaStem Therapeutics IncUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A